The macrophage-derived itaconate in the TME enhances of tumor cell survival by stabilizing NRF2 protein while suppressing the infiltration and functional activation of CD8+ T cells, which contributes to radioresistance of NSCLC. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.